Gilead Drug Flops In First Trial
Channel: AmplifyME
Date: 2020-04-24

Head of Market Analysis Anthony Cheung delivers a look ahead for the session. Topics covered include:

- Overview of sentiment at the European open (00:00)
- Tips on preparing for the trading day ahead (2:00)
- Gilead antiviral drug remdesivir flops in first trial (5:32)
- What's expected from the ECB next week as governments still disagree on the best way to finance a pandemic response (8:15)
- Update on the energy market and progress of OPEC+ deal being implemented (12:27)
- Summary of the calendar for the session ahead (15:00)

Like and Subscribe for more daily market analysis and reaction.

Find out more about Amplify Trading: https://www.amplifytrading.com/traders

Social Media handles: 

►Twitter: @amplifytrading @AWMCheung 

►Instagram: @askamplify @amplify_ant